Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

System and process for purification of Astatine-211 from target materials

Patent ·
OSTI ID:1998263

A new column-based purification system and approach are described for rapid separation and purification of the alpha-emitting therapeutic radioisotope 211At from dissolved cyclotron targets that provide highly reproducible product results with excellent 211At species distributions and high antibody labeling yields compared with prior art manual extraction results of the prior art that can be expected to enable enhanced production of purified 211At isotope products suitable for therapeutic medical applications such as treatment of cancer in human patients.

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RL01830
Assignee:
Battelle Memorial Institute (Richland, WA)
Patent Number(s):
11,621,097
Application Number:
17/586,647
OSTI ID:
1998263
Country of Publication:
United States
Language:
English

References (6)

A simple isolation of 211At using an anion-exchange spin column method journal October 2020
An automated flow system incorporating in-line acid dissolution of bismuth metal from a cyclotron irradiated target assembly for use in the isolation of astatine-211 journal April 2017
Investigation of a tellurium-packed column for isolation of astatine-211 from irradiated bismuth targets and demonstration of a semi-automated system journal November 2019
Automated astatination of biomolecules – a stepping stone towards multicenter clinical trials journal July 2015
Evaluation of Novel Wet Chemistry Separation and Purification Methods to Facilitate Automation of Astatine-­211 Isolation report July 2016
Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine journal September 2013

Similar Records

System and process for purification of astatine-211 from target materials
Patent · Mon Feb 21 23:00:00 EST 2022 · OSTI ID:1892645

Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B
Journal Article · Fri Dec 14 23:00:00 EST 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23105667

A Solid-State Support for Separating Astatine-211 from Bismuth
Journal Article · Fri Apr 17 00:00:00 EDT 2020 · Inorganic Chemistry · OSTI ID:1688758

Related Subjects